The studies of her group focus on biomarkers and causal pathways for metabolic health, ageing and longevity. Particular interest of her group is the genomic basis of osteoarthritis and cardiovascular disease (genetic, transcriptome and epigenetic studies) and development of biomarker profiles for these diseases and healthy ageing/longevity. Her research into stimulation of healthy ageing is focused on lifestyle intervention studies in humans (GOTO).
Slagboom has/had a leading roles in large consortia. She was coordinator of IDEAL, a large scale FP7-EU project (Integrated research on DEvelopmental determinants of Aging and Longevity) and co-director of the Netherlands Consortium for Healthy Ageing. In both large scale consortia she collaborated with multiple private parties. She is board member of EU collaborative research projects, BBMRI-NL (Bio banking and Biomolecular Resources Research Infrastructure) and the national studies in metabolomics (25 cohorts).
Last updated: 3.2.2020